Back to News
Market Impact: 0.12
WuXi Biologics Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership
Source: PR Newswire
ESG & Climate PolicyGreen & Sustainable FinanceHealthcare & Biotech
WuXi Biologics was named to the 2026 Forbes China ESG 50 list, recognized for sustainable-development performance, Green CRDMO solutions and ESG digital innovation. The recognition supports the company's ESG credentials but contains no financial results, guidance, or material operating update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
More News
- SpaceX loses bid to toss NAACP lawsuit over Memphis data center air pollution
- Judge allows NAACP lawsuit over xAI data center pollution to move forward
- ‘Like Kashmir’: How a toxic marble dump yard became a tourist spot in India
- Bolivia declares state of emergency over El Nino weather pattern
- Swiss firms plan to expand China investments as trade deal deepens ties
- Countries reach COP17 deal to speed up biodiversity action, but money still short